pentobarbital will lessen the extent or outcome of fentanyl transmucosal by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Monitor Closely. Coadministration of fentanyl with CYP3A4 inducers could lead to the minimize in fentanyl plasma concentrations, insufficient efficacy or, perhaps, improvement of a withdrawal syndrome in